Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 6 Jun 23 EFFECT Notice of effectiveness
- 1 Jun 23 POS AM Prospectus update (post-effective amendment)
- 24 Mar 22 EFFECT Notice of effectiveness
- 22 Mar 22 POS AM Prospectus update (post-effective amendment)
-
22 Mar 22 POSASR Automatic shelf registration (post-effective amendment)
- 30 Apr 21 424B5 Prospectus supplement for primary offering
- 16 Mar 21 S-3ASR Automatic shelf registration
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 16, 2021, with respect to the consolidated financial statements of TCR2 Therapeutics Inc., incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Boston, Massachusetts
March 22, 2022